Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer, BioNTech’s final Covid-19 vaccine study shows 95% efficacy

pharmaceutical-technologyNovember 19, 2020

Tag: Pfizer , BioNTech , BNT162B2 , COVID-19 vaccine

PharmaSources Customer Service